Posts Tagged ‘depression’

Anxiety, Depression, and Change with Mel Schwartz

Sunday, June 17th, 2018

Mel Schwartz LCSW, MPhil is a psychotherapist and marriage counselor in private practice in Westport, CT and Manhattan for over 20 years. He is an emerging voice in the field of personal transformation and is one of the first practicing psychotherapists to integrate the principles of quantum physics into a psychotherapeutic approach. He earned his graduate degree from Columbia University and has been a keynote speaker at Yale University. Mel is also the author of THE ART OF INTIMICY, THE PLEASURE OF PASSION, and he blogs for Psychology Today. His TEDx talk, OVERCOMING ANXIETY illuminates his approach for transcending this affliction. He has written over 100 articles, read by more than 2 million people. Mel works with individuals and organizations globally. He has also written numerous books including his latest The Possibility Principle: How Quantum Physics can improve the way you think, live, and love. He is also listen in Wikipedia. More information at: www.melschwartz.com

Enjoy the Interview below:

 

Can Depression Influence Lung Cancer Survival?

Wednesday, October 19th, 2016

Logos 005

A new study published in the Journal of Clinical Oncology on October 3 concluded that worsening symptoms depression are associated with shorter survival for lung cancer patients, especially for those in the early stages of the disease. On the other hand, when symptoms lift, survival tends to improve. Researchers said “This study cannot prove causation–but it lends support to the idea that surveillance for depression symptoms and treatment for depression could provide significant impact on patients outcomes, perhaps even a mortality benefit.” They also said “Suprisingly, depression remission was associated with a mortality benefit as they had the same mortality as never-depressed patients.”

In the study more than 1700 newly diagnosed lung cancer patients between 2003 and 2005 who had completed an eight item depression assessment at diagnoses and 12 months later were followed. they found almost 40 percent or 681 people had depressive symptoms at diagnosis and 14 percent or 105 people developed new-onset symptoms during treatment. Those depressed at the beginning of the study were 17 percent more likely to die during follow up than those with out depressive symptoms. Those (105 patients) with newly-diagnosed depression symptoms were 50 percent more likely to die than those (640 patients) who never developed depression. And another 254 patients whose depression lasted throughout the study period were 42 percent more likely to die. However, those whose depression at diagnoses were free of depression one year later had the same risk of death as those without depression.

Researchers concluded “Clinicians have to do a better job of treating the whole person and not focusing on the disease only.” “From the patients’ perspective, hopefully some of them will take a look at this study and realize the feelings they arew experiencing are common and they will feel empowered to advocate for themselves and ask their clinician for help or resources when they need it.”

Can a Single Dose of Magic Mushrooms Reduce Anxiety and Depression in Life Threatening Cancer Patients?

Wednesday, December 16th, 2015

logo1267406_mdA new study presented at the annual meeting of the American College of Neuropsychopharmacology concluded that a single dose of psilocybin, the major hallucinogenic compound in magic mushrooms. Induced decreases in depression and anxiety that lasted up to six months in patients with life threatening cancer. In the study the researchers studied the effects of psilocybin on them after receiving one dose significantly high enough to induce changes in perception and mystical type experiences. Patients reported significantly lower levels of anxiety and depression compared with patients who received a low dose of the drug and this positive effect lasted 6 months.

Is there an Association between Depression and Prostate Cancer Survival, Stage, and Effectiveness of Treatment?

Wednesday, July 16th, 2014

logo1267406_md

A new population observational study study published in the online Journal of Clinical Oncology concluded that depressed men with localized prostate cancer were more likely yo be diagnosed with more aggressive prostate cancer, receive less effective treatment, and survive a shorter time than those with prostate cancer but no depression., Rcsearchers studied patients from the Surveillance, Epidemiology and End Results (SEER) medicare database focusing on over 41,000 men diagnosed with localized prostate cancer diagnosed between 2004 and 2002007 and observed through 2009. Researchers identified 1,694 men diagnosed with depression among that group. .The study also found that with prostate cancer who were older, lower income. who had other medical problems , were white or Hispanic. who were unmarried and those living in non-metropolitan areas were more likely to be depresses. They also found that depressed men were more likely to seek out physicians in the two years before diagnoses but were less likely to seek out definitive treatment such aa surgery or radiation in contrast to those not depressed. They said “men with intermediate or high-risk prostate cancer and a recent diagnoses of depression are less likely to undergo definitive treatment and experience worse overall survival. It was concluded that more research was needed to validate these observatiojs.

 

Show with Dr Annette Poizner (graphology and psychotherapy) and Paul Huljick (stress management) now Available.

Sunday, October 27th, 2013

Annette Poizner_Print_13PaulHuljich_headshotInterviews for the show yesterday were with Dr Annette Poizner (left) and Paul Huljick. Dr Poizner is a practicing psychotherapist who uses graphology in her practice. She is author of Clinical Graphology: An Interpretive Manual for Mental Health Practitioners and many articles. More information was presented earlier on this site and can be found at: http://www.AnnettePoizner.com

Paul Huljick is Chairman and Joint CEO and Co-Founder of Best Corporation, a pioneering organic food business. He authored Stress Pandemic and Betrayal of Love and Freedom. He has appeared on over 180 radio shows as well as television and magazine interviews. More information was presented earlier on this site and can be found at: http://www.StressPandemic.com

Enjoy the Show:

 

 

Hypnosis, Herbs, and Diabetes Interventions

Sunday, December 11th, 2011

Dr Stefan Ripich (left), Dr Joe Ahrens (center) and Devin Hastings were interviewed yesterday by Dr Carl O Helvie, Host, Holistic Health Show. Dr Ripich is a naturopathic physician and certified nurse practitioner who is in private practice in New Mexico and is author of the 30 Day Diabetes Cure. More information is available at: http://www.30daydiabetescure.com

Dr Joe Ahrens is CEO of ATM Metabolics, LLC, and has authored The Grapefruit Solution more information is available at: http://www.atmmetabolics.com

Devin Hastings is President of Minnesota Institute of Advanced Communications Skills and Owner, of MindBodyHypnosis. He is author of several books including 21st Century Medicine: New Answers for Those Who Suffer in Silence; Control Your Diabetes With Hypnosis: Anxiety, OCD and Hypnosis: New Answers for Those who Suffer in Silence: and Become a Certified Diabetes Motivational Coach. More information is available at: http://www.miacs.net

Enjoy the Interview Below.

Research Finds Chantix is Unsuitable for First-Line Smoking Cessation

Friday, November 11th, 2011

chelvie4b

Research published in the November 2 issue of PLoS ONE concluded varenicline (Chantix) is unsuitable for first line use for smoking cessation because of its poor safety profile. Results showed a -substantially increased risk of reported depression or suicidal behavior compared to other smoking cessation treatments. Ninety-percent of all reported suicides related to smoking-cessation drugs since 1988 implicated Chantix despite the fact that it was only on the market 4 of the 13 years of the study. In addition, it was eight times more likely to result in a reported case of suicidal behavior or depression than nicotine replacement products and was associated with more suicidal behavior than any other smoking-cessation drug on the U.S. market. The researchers analyzed 3,249 case reports of serious injury from the FDA’s Adverse Event Reporting System between 1998 and September, 2010 for self-injurious behavior or depression related to Chantix, Zyban (bupropion) and nicotine replacement products. For suicidal behavior and depression 90% (2,925 cases) were related to Chantix, 7% (229) related to Zyban, and 3% (95) were related to nicotine replacement products. The researchers also said there are other safety issues with Chantix found by other researchers. They concluded “We agree with the recommendation of the U.S., Veterans Administration (VA) that varenicline should be prescribed only after failure of nicotine replacement , bupropion or a combination.” They further said “We
strongly recommend that the FDA should revise the black box warning to say what the study and the FDA ‘s own data shows–that varenicline has higher risks for suicidal behavior and depression than other smoking-cessation treatments.” .

Breast Cancer Outcomes Influenced by Depression

Wednesday, November 9th, 2011

logo1267406_md

Recent research published in Psychology and Health concluded that certain factors such as marital status, having children in the home, income level, and age affect the probability of depression among breast cancer survivors that in turn, affects the likelihood of failure to adhere to the medical regimes causing potential complications. The researcher studied who is more likely to be distressed following a breast cancer diagnosis and when depressive symptoms are most likely to occur during the course of treatment. During the year following treatment single women and women with children in the home were more likely to be depressed and these women may need additional support during this period.
Women of different income levels seemed to have similar levels of increased depression during treatment but these symptoms decreased in women of higher incomes in the year following treatment. Younger cancer survivors had more depression during treatment than older women but reported levels similar to the older women following treatment. The researcher believes that identifying these factors that influence depression in cancer survivors is an important part of the prognosis since this can influence the treatment regime and outcome of the disease.

Shorter Head and Neck Cancer Patient's Survival Associated with Stress and Depression

Friday, May 6th, 2011

logo1267406_md

In a study presented at the 32nd Annual Meeting and Scientific Sessions of the Society of Behavioral Medicine last month, researchers found an association between survival in early stage cancer patients and psychosocial function. Following upon research that shows that stress can affect the immune system and weaken the cancer patient’s defenses and also affect the tumors ability to grow and spread the researchers found that poor psychological functioning was associated with greater vascular endothelial growth factor (VEGF) expression. This signaling protein stimulates tumor growth and is associated with shorter disease-free survival in head and neck cancer patients.

In their study, 37 newly diagnosed, pre-surgical head and neck cancer patients were evaluated to see if psychological functioning (perceived stress, social support and depression) was associated with VEGF. Subjects were mostly male (70.3%). average of 57 years of age, and with a primary tumor site in the oral cavity (65.9%), larynx (19.9%). and oropharynx (13.5%), and early-stage disease (over 40%).
Subjects were given a psychological questionaire prior to treatment that measured psychological functioning. In addition, VEGF expression in tumor tissue was obtained during surgery and evaluated using a process that helps detect the presence of specific proteins. Results showed that higher levels of perceived stress and depression symptoms were associated with greater VEGF expression in the tumor tissue of these patients and the association between psychological functioning and VEGF were stronger among early-stage subjects. Researchers concluded that “In patients with advanced cancers, psychosocial interventions may have less of an impact since these cancers are inherently more aggressive.”
More research is planned.

Three Individuals Interviewed Who Used Faith in Healing

Sunday, October 31st, 2010

carolyn jones

rschooping

cheryl petersen

On Saturday Dr Carl O Helvie, host, Holistic Health Show, interviewed three guests who used faith in their healing. They are Carolyn Jones, right, Richard Schooping, and Cheryl Petersen.

Carolyn is a registered nurse and author of Opening the Gates of the Heart: A Journey of Healing. More information about her was presented earlier on this site and can be found at http://www.gatelady.com

Richard writes about his AIDS experience in his first book From suffering to Soaring. He is also a singer and songwriter. More information is available earlier on this site and at www.richardschooping.com

Cheryl recovered from an auto accident and updated Science and Health with Keys to the Scriptures. More information was presented earlier on this site and can be found at: www.HealingScienceToday.com